Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease

Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab

(2009) Kazuko Matsumoto et al.   CLINICAL RHEUMATOLOGY

Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis

(2009) Francisco Hélder C. Félix et al.   RHEUMATOLOGY INTERNATIONAL

Tocilizumab for multirefractory adult-onset Still's disease

(2008) M De Bandt et al.   ANNALS OF THE RHEUMATIC DISEASES

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

(2008) N. Nishimoto et al.   BLOOD

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

(2008) Shumpei Yokota et al.   LANCET

A case report of a patient with refractory adult-onset Still’s disease who was successfully treated with tocilizumab over 6 years

(2008) Hideko Nakahara et al.   Modern Rheumatology